Why is it that some tumors worsen quickly, while others stop growing on their own or even shrink? Breakthrough research from the laboratory of Technion Distinguished Professor Aaron Ciechanover discovered two proteins that could suppress malignant tumor growth.
The Technion is one of the few institutions worldwide that brings together biology with the physical sciences and engineering, to translate research more quickly into clinical solutions. Profs. Ciechanover and Avram Hershko’s Nobel winning researchers’ discovery led to the drug — Velcade — for the treatment of multiple myeloma. Other Technion scientists have made great strides in identifying biomarkers for early cancer detection, combating drug-resistant tumors, and developing personalized medicine and targeted drug delivery.
The Technion Integrated Cancer Center takes advantage of the Technion’s multidisciplinary research teams and its location next to Rambam Medical Center, building upon the foundation of earlier cancer research at the David and Janet Polak Center for Cancer Research and Vascular Biology. Leading doctors and scientists — including clinicians/oncologists, protein chemists, structural biologists, electrical engineers, computer scientists and others — work together to help combat cancer in a comprehensive manner.
The TICC is being led by the generous support of noted philanthropists the Crown Family and Laura and Isaac Perlmutter.
Recent Breakthroughs in Cancer Research
A new study by researchers at the Technion could hold a key to control cancer cell growth and development. The development of a cancer-fighting drug based on this discovery is a possibility.
Technion Professor Hossam Haick has developed an electronic nose that could allow for the early detection of stomach cancer—one of the most lethal forms of cancer— and for identifying people at risk of developing the disease.
A team of researchers led by Techinon Professor Ester Segal found that silicon nanomaterials used for the localized delivery of chemotherapy drugs behave differently in cancerous tumors than they do in healthy tissues. The findings could help scientists better design such materials to facilitate the controlled and targeted release of the chemotherapy drugs to tumors.
Click below to watch more Technion videos on the fight against cancer:
For more information, please write to email@example.com